Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment-Related Toxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06986291
What this trial is testing

Radiation-induced Toxicity of the Heart

Who this might be right for
Non-small Cell Lung CancerEsophageal CancerBreast Cancer Female
Technische Universität Dresden 325
Not applicableStudy completedNCT07272538
What this trial is testing

Predicting Chemotherapy Toxicity Using FRAIL and FIND in Older Adults With Gastrointestinal Cancers

Who this might be right for
Gastrointestinal CancersFrailty at Older AdultsChemotherapy
Ankara Etlik City Hospital 84
Not applicableEnded earlyNCT05029154
What this trial is testing

Exercise Preconditioning in Ovarian Cancer

Who this might be right for
Ovarian Cancer
University of Virginia 8
Testing effectiveness (Phase 2)WithdrawnNCT02319616
What this trial is testing

Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis

Who this might be right for
Toxic Epidermal Necrolysis
University of California, Davis
Not applicableLooking for participantsNCT07273812
What this trial is testing

Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients

Who this might be right for
Breast CancerBreast NeoplasmChemotherapy-Related Toxicities+4 more
Dena h. Al-Tameemi 130
Post-approval studies (Phase 4)Looking for participantsNCT05465031
What this trial is testing

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Who this might be right for
Breast CancerNeoplasm, BreastBreast Diseases+10 more
Silesian Centre for Heart Diseases 600
Early research (Phase 1)Study completedNCT04023110
What this trial is testing

Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab

Who this might be right for
CardiotoxicityRisk Factor, CardiovascularToxicity Due to Chemotherapy+3 more
Abramson Cancer Center at Penn Medicine 68
Not applicableEnded earlyNCT03849950
What this trial is testing

Self-Management and Activation to Reduce Treatment-Related Toxicities (SMARTCare)

Who this might be right for
LymphomaLung CancerColo-rectal Cancer
University Health Network, Toronto 62
Not applicableUnknownNCT05927636
What this trial is testing

Systemic Treatment Related Toxicity Identified With a Smartphone APPlication Measuring Step Count

Who this might be right for
CancerSystemic TreatmentPhysical Activity+1 more
Radboud University Medical Center 411
Not applicableStudy completedNCT01328457
What this trial is testing

An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh

Who this might be right for
Visceral Leishmaniasis
PATH 120
Large-scale testing (Phase 3)Study completedNCT00003313
What this trial is testing

Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung CancerOral Complications+1 more
Radiation Therapy Oncology Group 243
Testing effectiveness (Phase 2)Study completedNCT05378360
What this trial is testing

DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities

Who this might be right for
Rash Acneiform
Daewoong Pharmaceutical Co. LTD. 96
Testing effectiveness (Phase 2)Looking for participantsNCT03847649
What this trial is testing

A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies

Who this might be right for
Cancer
Canadian Cancer Trials Group 60
Not applicableUnknownNCT05292456
What this trial is testing

Monıtorıng Glucocortıcoıd Treatment In Patıents Followed In Rheumatology Clınıc

Who this might be right for
Glucocorticoids ToxicityRheumatoid ArthritisVasculitis+1 more
Hacettepe University 200
Early research (Phase 1)Study completedNCT00003268
What this trial is testing

Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemia
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Large-scale testing (Phase 3)UnknownNCT05728632
What this trial is testing

Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines

Who this might be right for
Breast CancerLymphoma, Large B-Cell, DiffuseCardiotoxicity+2 more
Giulio Stefanini 80
Testing effectiveness (Phase 2)Study completedNCT00004567
What this trial is testing

Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes

Who this might be right for
VasculitisWegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID) 75
Testing effectiveness (Phase 2)Looking for participantsNCT04711200
What this trial is testing

LYell SYndrome MEsenchymal Stromal Cells Treatment

Who this might be right for
Epidermal NecrolysisLyell SyndromeToxic Epidermal Necrolysis+3 more
Assistance Publique - Hôpitaux de Paris 15
Not applicableWithdrawnNCT01349556
What this trial is testing

Prevention of Drug Rash From Certain Cancer Therapies Using Tretinoin Cream

Who this might be right for
Medication Reaction
Johns Hopkins University
Not applicableStudy completedNCT01015326
What this trial is testing

Development of Dermatology-related Quality of Life Assessment in Patients Treated With Epidermal Growth Factor Receptor (EGFR) Inhibitors

Who this might be right for
Skin Toxicities
Northwestern University 32
Next Page